Infectious Diseases News and Research

RSS

Smartphone-based COVID-19 detection system

In this interview, we speak to Professor Michael Mahan about his latest research which aimed to bring low-cost, state-of-the-art diagnostics to resource-limited settings.

17 Feb 2022

Detection of SARS-CoV-2 RNA by plasmonic-magnetic nanorobots

Researchers present a simple and efficient plasmonic-magnetic nanorobot for the detection of SARS-CoV-2 RNA.

16 Feb 2022

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications.

16 Feb 2022

SARS-CoV-2 variants are evolving increased infectivity and antibody escape, studies say

First announced by the World Health Organization on Nov. 26, 2021, the SARS-CoV-2 omicron variant spread rapidly around the world, becoming the dominant variant in the U.S. and elsewhere.

16 Feb 2022

Study finds higher mortality rates among African children and adolescents hospitalized with COVID-19

African children and adolescents hospitalized with COVID-19 experience much higher mortality rates than Europeans or North Americans of the same age, according to a recently published study conducted by researchers from the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) and the Institute of Human Virology Nigeria (IHVN).

16 Feb 2022

New cholera vaccine generates long-lasting antibody responses in mice

Cholera, a diarrheal disease caused by the highly transmissible bacteria Vibrio cholerae, kills tens of thousands of people each year worldwide.

16 Feb 2022

The emergence of infectious diseases from the "germ’s eye view”

The study highlighted that the disruption caused by the COVID-19 pandemic has shown that human societies remain ill-prepared and susceptible to novel infectious diseases.

16 Feb 2022

Government asks experts to inform the refresh of UK's Biological Security Strategy

The Government is today (Wednesday 16 February) asking for health and security experts to inform the refresh of the UK's Biological Security Strategy, which aims to protect the country from a range of biological threats, including emerging infectious diseases and potential misuse by hostile actors.

15 Feb 2022

Stem cell infusion improves the survival of mice with sepsis

A one-time infusion of stem cells from bone marrow improves the survival of mice with sepsis, shows a study published today in eLife.

15 Feb 2022

Lifting mask mandates in elementary schools in the U.S. may be too early, study finds

Before lifting mask mandates in elementary schools in the U.S., local COVID-19 case rates should be far below current rates to avoid the risk of increased transmission among students, staff, and families, according to a study led by researchers at Harvard T.H. Chan School of Public Health and Massachusetts General Hospital.

15 Feb 2022

A third known case of HIV remission involving stem cell transplant documented

A woman with HIV who received a cord blood stem cell transplant to treat acute myeloid leukemia has had no detectable levels of HIV for 14 months despite cessation of antiretroviral therapy (ART), according to a presentation at today's Conference on Retroviruses and Opportunistic Infections (CROI).

15 Feb 2022

Can N95 respirators be safely re-processed?

Can N95 respirators be safely re-processed? We speak to Christina Yen, an infectious diseases physician, to find out.

15 Feb 2022

SARS-CoV-2 transmission in transmission pairs of school-aged children during the COVID-19 pandemic in the Netherlands

Researchers evaluated whether SARS-CoV-2 transmission among school-aged children in the Netherlands follows a bipartite school and household network.

15 Feb 2022

Researchers identify a powerful combination of antivirals to treat COVID-19

Researchers at the University of Maryland School of Medicine and University of Pennsylvania Perelman School of Medicine have identified a powerful combination of antivirals to treat COVID-19.

14 Feb 2022

Study finds mRNA vaccines induce poor neutralizing antibody response against SARS-CoV-2 variants in dialysis patients

Scientists studied plasma samples from 130 hemodialysis (HD) and 13 peritoneal dialysis patients and showed a poor neutralizing and rapidly decaying antibody response to mRNA vaccines in such individuals.

14 Feb 2022

CDC study first to show waning immunity after third dose of mRNA COVID-19 vaccine

A nationwide study from the U.S. Centers for Disease Control and Prevention is the first to show that immunity against severe COVID-19 disease begins to wane 4 months after receipt of the third dose of an mRNA vaccine (Pfizer or Moderna).

12 Feb 2022

Study points to vagus nerve dysfunction as a central pathophysiological feature of long COVID

New research to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2022, Lisbon, 23-26 April) suggests that many of the symptoms connected to post-COVID syndrome (PCC, also known as long COVID) could be linked to the effect of the virus on the vagus nerve – one of the most important multi-functional nerves in the body.

12 Feb 2022

Performance of SARS-CoV-2 antibodies improves only after previous infection, not vaccination

New research to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon, 23-26 April) shows that, although over time the number of SARS-CoV-2 antibodies falls in both previously infected and vaccinated patients, the performance of antibodies improves only after previous infection (and not vaccination).

11 Feb 2022

Omicron resists antibodies, causes less severe disease than previous SARS-CoV-2variants

In two recent studies, researchers at Washington University School of Medicine in St. Louis found evidence that the omicron variant of the virus that causes COVID-19 causes less severe disease than previous variants — at least in rodents — but that many antibody-based therapies may not be effective against it.

10 Feb 2022

Study shows immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in Congolese populations

A new study by UCLA researchers and colleagues demonstrates that the Ebola vaccine known as rVSVΔG-ZEBOV-GP results in a robust and enduring antibody response among vaccinated individuals in areas of the Democratic Republic of Congo (DRC) that are experiencing outbreaks of the disease.

10 Feb 2022

Infectious Diseases News and Research

Smartphone-based COVID-19 detection system

Detection of SARS-CoV-2 RNA by plasmonic-magnetic nanorobots

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

SARS-CoV-2 variants are evolving increased infectivity and antibody escape, studies say

Study finds higher mortality rates among African children and adolescents hospitalized with COVID-19

New cholera vaccine generates long-lasting antibody responses in mice

The emergence of infectious diseases from the "germ’s eye view”

Government asks experts to inform the refresh of UK's Biological Security Strategy

Stem cell infusion improves the survival of mice with sepsis

Lifting mask mandates in elementary schools in the U.S. may be too early, study finds

A third known case of HIV remission involving stem cell transplant documented

Can N95 respirators be safely re-processed?

SARS-CoV-2 transmission in transmission pairs of school-aged children during the COVID-19 pandemic in the Netherlands

Researchers identify a powerful combination of antivirals to treat COVID-19

Study finds mRNA vaccines induce poor neutralizing antibody response against SARS-CoV-2 variants in dialysis patients

CDC study first to show waning immunity after third dose of mRNA COVID-19 vaccine

Study points to vagus nerve dysfunction as a central pathophysiological feature of long COVID

Performance of SARS-CoV-2 antibodies improves only after previous infection, not vaccination

Omicron resists antibodies, causes less severe disease than previous SARS-CoV-2variants

Study shows immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in Congolese populations

Industry Focus: Infectious Diseases eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News